Effectiveness of a Treatment Switch to Nevirapine plus Tenofovir and Emtricitabine (or Lamivudine) in Adults with HIV-1 Suppressed Viremia

BACKGROUND: Switching subjects with persistently undetectable HIV-1 viremia under antiretroviral treatment (ART) to once-daily tenofovir/emtricitabine (or lamivudine) + nevirapine is a cost-effective and well-tolerated strategy. However, the effectiveness of this approach has not been established. M...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:PLoS One
Auteurs principaux: Llibre, Josep M., Bravo, Isabel, Ornelas, Arelly, Santos, José R., Puig, Jordi, Martin-Iguacel, Raquel, Paredes, Roger, Clotet, Bonaventura
Format: Artigo
Langue:Inglês
Publié: Public Library of Science 2015
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4479501/
https://ncbi.nlm.nih.gov/pubmed/26107265
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0128131
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires